School of Medicine

Researcher Deanna Barch, a professor at WashU, has received a lifetime achievement award from the Association for Psychological Science.

Three WashU investigators have been recognized with prestigious awards through the National Institutes of Health (NIH) Director’s High-Risk, High-Reward Research program, which supports unconventional approaches to major challenges in biomedical and behavioral research.

New research from WashU Medicine identified a key enzyme that enables rotavirus to infect cells. Disabling this enzyme prevented infection, suggesting new treatments against rotavirus and other pathogens that rely on similar mechanisms.

WashU Medicine researchers led by Erik Musiek, MD, PhD, discovered in mice that inhibition of a protein that controls the daily cycling of metabolism and inflammation decreases neurodegeneration in Alzheimer’s disease.

WashU Medicine researchers found that immune cells that dispose of the body’s cellular debris can protect insulin-producing cells and prevent Type 1 diabetes in mice.

Neuroscientists, clinicians and engineers at Washington University in St. Louis seek to develop personalized medicine strategies for refractory depression that would tailor drug dosage based on a patient’s age, genetics, health conditions, brain dynamics and neural circuits.

Kim and Tim Eberlein, MD, were recently honored with the 2025 Jane and Whitney Harris St. Louis Community Service Award. The honor recognizes couples who contribute to the betterment of the greater St. Louis community.

A multidisciplinary team of researchers at Washington University in St. Louis plans to investigate the neural mechanisms behind various controls of transcutaneous spinal cord stimulation in generating different leg movements with a five-year, nearly $3 million grant the National Institutes of Health (NIH).

Jeannie Kelly, MD, a renowned expert in the care of women with opiate use disorders during pregnancy, has been named the new director of the Division of Maternal-Fetal Medicine & Ultrasound in the Department of Obstetrics & Gynecology at WashU Medicine.

WashU Medicine researchers received a grant from the National Institutes of Health (NIH) that will help speed development of an enhanced version of naloxone, known by the brand name Narcan.